BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27916712)

  • 1. Prognostic Significance of the Proportion of Ductal Component in Ductal Adenocarcinoma of the Prostate.
    Jang WS; Shin SJ; Yoon CY; Kim MS; Kang DH; Kang YJ; Jeong WS; Cho NH; Choi YD
    J Urol; 2017 Apr; 197(4):1048-1053. PubMed ID: 27916712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.
    Magheli A; Rais-Bahrami S; Peck HJ; Walsh PC; Epstein JI; Trock BJ; Gonzalgo ML
    J Urol; 2007 Oct; 178(4 Pt 1):1311-5. PubMed ID: 17698095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy.
    Savdie R; Horvath LG; Benito RP; Rasiah KK; Haynes AM; Chatfield M; Stricker PD; Turner JJ; Delprado W; Henshall SM; Sutherland RL; Kench JG
    BJU Int; 2012 Jun; 109(12):1794-800. PubMed ID: 21992536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.
    Han M; Partin AW; Zahurak M; Piantadosi S; Epstein JI; Walsh PC
    J Urol; 2003 Feb; 169(2):517-23. PubMed ID: 12544300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extension.
    Samaratunga H; Duffy D; Yaxley J; Delahunt B
    Hum Pathol; 2010 Feb; 41(2):281-5. PubMed ID: 20004936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of postoperative neutrophil-to-lymphocyte ratio after radical prostatectomy for localized prostate cancer.
    Jang WS; Cho KS; Kim MS; Yoon CY; Kang DH; Kang YJ; Jeong WS; Ham WS; Choi YD
    Oncotarget; 2017 Feb; 8(7):11778-11787. PubMed ID: 28052031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Significance of Vas Deferens Invasion After Radical Prostatectomy in Patients with Pathological Stage T3b Prostate Cancer.
    Jang WS; Yoon CY; Kim KH; Kang YJ; Shin SJ; Cho NH; Lee JY; Cho KS; Ham WS; Rha KH; Hong SJ; Choi YD
    Ann Surg Oncol; 2017 Apr; 24(4):1143-1149. PubMed ID: 27796593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma.
    Hattab EM; Koch MO; Eble JN; Lin H; Cheng L
    J Urol; 2006 May; 175(5):1695-9; discussion 1699. PubMed ID: 16600733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of patient age on biochemical recurrence rates following radical prostatectomy.
    Magheli A; Rais-Bahrami S; Humphreys EB; Peck HJ; Trock BJ; Gonzalgo ML
    J Urol; 2007 Nov; 178(5):1933-7; discussion 1937-8. PubMed ID: 17868723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter clinical validation of PITX2 methylation as a prostate specific antigen recurrence predictor in patients with post-radical prostatectomy prostate cancer.
    Bañez LL; Sun L; van Leenders GJ; Wheeler TM; Bangma CH; Freedland SJ; Ittmann MM; Lark AL; Madden JF; Hartman A; Weiss G; Castaños-Vélez E
    J Urol; 2010 Jul; 184(1):149-56. PubMed ID: 20478579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathological features of ductal adenocarcinoma of the prostate in 1,051 radical prostatectomy specimens.
    Seipel AH; Wiklund F; Wiklund NP; Egevad L
    Virchows Arch; 2013 Apr; 462(4):429-36. PubMed ID: 23443941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and long-term survival after radical prostatectomy.
    Chalfin HJ; Lee SB; Jeong BC; Freedland SJ; Alai H; Feng Z; Trock BJ; Partin AW; Humphreys E; Walsh PC; Han M
    J Urol; 2014 Oct; 192(4):1100-4. PubMed ID: 24769031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Factors for Biochemical Recurrence More than 10 Years after Radical Prostatectomy.
    Liesenfeld L; Kron M; Gschwend JE; Herkommer K
    J Urol; 2017 Jan; 197(1):143-148. PubMed ID: 27418452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of pathological factors on oncological outcomes after robot-assisted radical prostatectomy for localized prostate cancer: Results of a prospective study.
    Kozal S; Peyronnet B; Cattarino S; Seisen T; Comperat E; Vaessen C; Mozer P; Renard-Penna R; Cussenot O; Rouprêt M; Drouin SJ
    Urol Oncol; 2015 Jul; 33(7):330.e1-7. PubMed ID: 25998747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular invasion predicts recurrence after radical prostatectomy: stratification of risk based on pathologic variables.
    Ferrari MK; McNeal JE; Malhotra SM; Brooks JD
    Urology; 2004 Oct; 64(4):749-53. PubMed ID: 15491714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Close surgical margins after radical prostatectomy mimic biochemical recurrence rates of positive margins.
    Whalen MJ; Shapiro EY; Rothberg MB; Turk AT; Woldu SL; Roy Choudhury A; Patel T; Badani KK
    Urol Oncol; 2015 Nov; 33(11):494.e9-494.e14. PubMed ID: 26259665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robotic assisted laparoscopic prostatectomy versus radical retropubic prostatectomy for clinically localized prostate cancer: comparison of short-term biochemical recurrence-free survival.
    Barocas DA; Salem S; Kordan Y; Herrell SD; Chang SS; Clark PE; Davis R; Baumgartner R; Phillips S; Cookson MS; Smith JA
    J Urol; 2010 Mar; 183(3):990-6. PubMed ID: 20083261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer.
    Bhatta-Dhar N; Reuther AM; Zippe C; Klein EA
    Urology; 2004 Mar; 63(3):528-31. PubMed ID: 15028451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radical prostatectomy in high-risk prostate cancer: incidence of specimen-confined disease (pT2-pT3a N0R0) and outcomes.
    Mearini L; Nunzi E; Bini V; Lepri L; Bruno R; Porena M
    Urologia; 2014; 81(2):125-32. PubMed ID: 24474543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.